Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their ...

More than 2 out of 5 American adults are obese, according to the Centers for Disease Control. With this figure in mind, it's ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

Seeking Alpha analyst Stephen Ayers shares his views on which weight-loss drug stock looks most attractive for investors ...

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

Former Playboy star Kendra Wilkinson revealed that she started taking a weight-loss drug but threw the medication away after ...

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs ... weight loss, lean mass, and fat mass reduction between those using tirzepatide and those using semaglutide.